|
HS Code |
155035 |
| Product Name | 4-Bromo-2,6-Difluorobenzoic Acid |
| Cas Number | 851777-31-2 |
| Molecular Formula | C7H3BrF2O2 |
| Molecular Weight | 237.00 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 142-144 °C |
| Purity | ≥98% |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Smiles | C1=CC(=C(C(=C1F)Br)F)C(=O)O |
| Inchi | InChI=1S/C7H3BrF2O2/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2H,(H,11,12) |
| Storage | Store at room temperature, keep container tightly closed |
As an accredited 4-Bromo-2,6-Difluorobenzoic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 25g of 4-Bromo-2,6-Difluorobenzoic Acid is supplied in a sealed amber glass bottle with a tamper-evident cap. |
| Shipping | 4-Bromo-2,6-Difluorobenzoic Acid is shipped in tightly sealed containers, protected from moisture and light. It is transported according to applicable chemical safety regulations, ensuring proper labeling and documentation. The package is cushioned to prevent breakage and typically sent by ground or air transport, depending on customer location and regulatory requirements. |
| Storage | **4-Bromo-2,6-difluorobenzoic acid** should be stored in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Avoid exposure to incompatible substances such as strong oxidizing agents and bases. Label storage clearly and keep away from heat sources to maintain chemical stability and ensure laboratory safety. |
Applications of 4-Bromo-2,6-Difluorobenzoic Acid in Industrial ManufacturingOur facility manufactures 4-Bromo-2,6-Difluorobenzoic Acid for use as a key intermediate in several industry-specific syntheses. Below we outline principal application scenarios where downstream manufacturers successfully integrate this compound into regulated and commercially validated production flows across pharmaceuticals, agrochemicals, and advanced material industries. 1. Pharmaceutical API Intermediate Synthesis4-Bromo-2,6-Difluorobenzoic Acid serves as a core building block during API synthesis campaigns where fluorinated aromatic intermediates impart metabolic stability and selective binding to pharmaceutical candidates. In production settings, manufacturers apply it within multi-step syntheses, typically coupling it with amine or heterocyclic moieties applicable to anti-infective and oncology assets. Reliable supply and batch-level consistency enable APIs to meet regulatory dossiers for worldwide export, providing the fluorine and bromo functionality essential for target molecule design. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Active Ingredient DevelopmentMajor agrochemical producers employ this compound as a precursor when developing high-affinity herbicide or insecticide candidates, thanks to the electron-withdrawing characteristics that benefit biological activity and environmental persistence. Formulators integrate it during route scouting of aromatic ring-substituted actives, leveraging its compatibility with halogenation sequences and its utility as a coupling partner in ether or amide bond construction. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Advanced Materials – Liquid Crystal Monomer SynthesisManufacturers in the electronics materials sector source this intermediate to construct halogenated monomers designed for high-performance liquid crystal (LC) applications. Its structural features facilitate the synthesis of rigid-core and semi-rigid mesogenic units, required in display-grade liquid crystals and specialty polymeric films. The compound enables precise molecular tuning of birefringence, dielectric anisotropy, and thermal stability in the final LC mixture. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Synthesis – Fluorinated Benzene DerivativesChemical synthesis firms utilize the compound for custom manufacture of specialty benzene-ring derivatives, where precise positioning of fluoro and bromo groups is critical for downstream reactivity and molecular recognition. These derivatives supply the life sciences, advanced electronics, and surface treatment industries. The acid group facilitates further diversification by amidation or esterification, tailored to niche performance attributes in high-value application spaces. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Pharmaceutical Impurity Reference Standards ProductionRegulated analytical labs and pharmaceutical makers require analytical reference standards to validate impurity and byproduct identification within regulated medicines. Because of its distinct bromo and difluoro substitutions, this compound serves as a precursor for trace impurity and metabolite synthesis that supports pharmacopoeia-compliant method development and routine batch-release testing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-2,6-Difluorobenzoic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of chemical manufacturing, certain raw materials keep turning up at the bench time after time, often for good reason. 4-Bromo-2,6-Difluorobenzoic Acid is one of those intermediates that gets called on regularly. Over years of working directly with this compound, I’ve learned its qualities lie not only in its structure, but in the reliability it brings to fine chemical synthesis. Every batch that runs through our reactors starts with a solid understanding of purity, reactivity, and the versatility that this acid brings to downstream transformations.
From a practical standpoint, the structure of 4-Bromo-2,6-Difluorobenzoic Acid – with a bromine atom on the fourth carbon and two fluorines on the aromatic ring – gives it specific electronic and steric properties. The model number CAS 25973-55-1 is the shorthand most chemists recognize, but in production, those numbers mean less than the hands-on handling. Typically, the product is delivered as a white to off-white crystalline powder. We focus on achieving high assay levels – not just to meet paper specs, but to prevent surprises in later coupling reactions or halogen-metal exchange.
Moisture content gets controlled within strict tolerances since even small amounts of water can compromise subsequent Grignard or Suzuki couplings. Trace metal content, residual solvents, and particulate contamination must be minimized because downstream users – both in pharma and agrochemical fields – expect consistency. Over the years, we’ve invested in upgrade after upgrade to filtration and purification equipment to push impurities well below the threshold where they actually affect performance.
Particle size distribution also counts, especially when the material heads into automated processes. Too much dust causes losses, too many large chunks slow down dissolution. By keeping D90 within the micron-size sweet spot, flowing across both manual and continuous systems stays hassle-free. We’ve tweaked mill settings and invested in inline sieves to match what scale-up chemists actually want.
Some customers ask why not just use a simpler benzoic acid or a less fluorinated version. In bench work, people quickly see that substituent patterns have real world impact. The two fluorines not only boost the ring’s electron-withdrawing ability, they add metabolic stability in pharmaceutical backbones. The bromine acts as a versatile handle for subsequent palladium-catalyzed coupling, allowing introduction of a huge variety of groups.
From our side, we’ve run parallel reactions with mono-fluorinated, non-halogenated, and even 4-chloro analogs to troubleshoot performance questions. Yields drop off, side products increase, or purification becomes more challenging once the substitution pattern changes. The hallmark of 4-Bromo-2,6-Difluorobenzoic Acid is the combination of reactivity and predictability. Even trace levels of impurities like 2,6-difluorobenzoic acid or dibromo analogs can derail a medicinal chemistry campaign, which is why extensive QC and batch records are a non-negotiable part of our process.
Our feedback from pharma and agrochemical groups runs across the spectrum, but a common thread runs through: versatility in derivatization. Medicinal chemists appreciate the room to maneuver offered by the aryl bromide moiety, especially for quick library synthesis. The difluorinated motif affords attractive physical and chemical properties, such as increased lipophilicity and improved metabolic profiles when building drug candidates.
On the process scale, manufacturing teams emphasize the benefit of predictable crystallinity and melting range. This allows smoother integration with next-step reactions, especially those involving nucleophilic aromatic substitution or coupling. We’ve worked alongside process chemists debugging scale-up and can attest to the pain that comes with highly polymorphic intermediates. The acid group confers advantageous solubility in polar solvents, aiding purification, but doesn’t behave so aggressively as to corrode common processing lines or filtration setups.
Not every batch runs perfectly, and real manufacturing experience means learning how to troubleshoot along the way. Humidity spikes mid-process? We see elevated agglomeration, so we’ve installed dehumidification units and increased in-process kitting to minimize exposure. Recrystallization sometimes produces larger-than-normal crystals, especially in colder seasons, which affects downstream filtration speed. By staggering addition rates and using seeded crystallization techniques, we’ve smoothed out a lot of the variability.
Every time an equipment upgrade occurs, we track not just analytic data, but operator feedback – how does the slurry pour, is the product too sticky, do the batches become harder to pack? One year, a slight reformulation to reduce static in powder handling saved an entire crew weeks of irritation. These lessons are hard-earned and rarely show up in a technical data sheet, but they determine whether a product truly works outside the lab notebook.
Downstream compliance teams always hunt for documentation that can connect batch-to-batch performance to analytical certificates. Our site anchors on full traceability. All 4-Bromo-2,6-Difluorobenzoic Acid batches receive authenticated COAs, and our in-house QC validates NMR, HPLC, GC, and IR results against customer-verified standards. In rare cases, a shipment with a slightly shifted melting range will trigger a full process review, often leading to better solvent conservation or an upgrade in drying techniques.
Analytical transparency matters. Over the years, new GMP regulations tightening trace metal limits, or the introduction of stricter analysis for residual solvents, have prompted us to overhaul both equipment and personnel training. Instead of just aiming for “pass/fail,” we build out full impurity profiles, tracking even low ppm halogenated or fluorinated byproducts, since those can show up as process contaminants later on.
The chemical sector doesn’t operate in a regulatory vacuum. Each year brings a fresh set of expectations – lower solvent residues, improved material storage, tighter environmental emission caps. For 4-Bromo-2,6-Difluorobenzoic Acid, the challenge often centers on responsible bromine and fluorine management. Halogenated waste can be expensive or difficult to treat. By shifting to cleaner extraction solvents and investing in solvent recycling systems, we’ve both cut costs and reduced environmental liability.
The past decade’s push towards green chemistry has influenced how many intermediates get produced and handled. We track waste output, look for new purification strategies that avoid chlorinated or otherwise problematic solvents, and reevaluate process steps each time a new guideline or customer sustainability requirement lands. We’ve piloted higher-yield methods and even adjusted the quench step to minimize unwanted side product formation, all aimed at higher atom economy.
Project lifecycles can last years, with researchers returning to order the same intermediate again and again. No one wants to troubleshoot a new impurity after a process transfer. We maintain archives of reference samples for every lot shipped, allowing for retrospective analysis should any issue arise. Occasionally, a customer will unveil a new route or process that places unique demands on our product. This sort of feedback loop has prompted us to offer custom packaging or granulation options. Some prefer foiled pouches to avoid light exposure, others need a drum tailored for robotic powder handling.
It is not unusual to have PhD-level chemists on a weekly call to discuss the subtle effects of water content or solvent traces on their scale-up. This back-and-forth doesn’t show up in catalog listings, but it feeds directly into how we update our batch protocols and packaging tools.
One area of rapid growth has been automated and flow-based chemistry. Many fine chemical manufacturers now rely on microreactors and rapid-injection setups. Our team gets regular requests for particle size tuning or to guarantee minimal static charge in the powder, facilitating smooth transport through automated systems. Sometimes this means fine-tuning the milling process or adding a cGMP-compliant anti-caking agent.
Photoredox and metal-catalyzed cross-coupling techniques continue to expand, with more groups using 4-Bromo-2,6-Difluorobenzoic Acid as a launching point for increasingly complicated molecular architectures. By keeping impurity and trace metal levels tracked and minimized, our product keeps pace with these high-sensitivity techniques.
Standing in front of a chemical reactor, watching temperatures climb and clocks tick, teaches a different kind of patience. Over the years, equipment hiccups, raw material inconsistencies, or even subtle changes in supplier quality have thrown wrenches in the process. Rather than seeking quick fixes, our team has built in regular line inspections, redundancy in supplier vetting, and small-scale pilot runs for new raw material sources.
Implementing lean manufacturing principles changed how our processes flow. We set up just-in-time inventory and use barcode tracking not because it’s trendy, but because fewer mistakes mean fewer headaches down the supply chain. These practices help avoid stock-outs and maintain responsive deliveries, minimizing the risk a customer’s process will shut down due to a missed shipment.
Feedback from large- and small-scale users alike has led us to maintain open lines of communication. If a process fails, we log the results, trace back all relevant data, and use it for direct process improvement. This approach has cut down on recurring issues and raised overall batch success rates over time.
To achieve higher product purity without unnecessary cost, we’ve continually experimented with process upgrades. For solvent-based purification, switching from batch to continuous extraction with in-line compositional monitoring has eased bottlenecks and reduced labor. In drying, we’ve piloted vacuum belt dryers for fragile crystals as opposed to older hot-air ovens, resulting in better residual solvent control and less thermal decomposition.
Laser particle size analyzers give more reliable signals than sieving or microscope estimation, cutting error rates in sample reporting. Investment in low-dust packing lines has reduced losses and operator exposure, making the workflow safer and more predictable. Our documentation ties every operational tweak to specific results, driving confidence in repeat orders.
Having run many aromatic acids over the years, the practical performance of 4-Bromo-2,6-Difluorobenzoic Acid stands out. Making a direct swap to a mono-fluorinated or plain benzoic acid leads to differences in reactivity, which affects both yield and selectivity. Swapping the bromine for chlorines shifts the balance in palladium catalysis, making some previously predictable transformations less efficient. Trace impurities or isomeric contamination, which seem minor, often balloon into real problems at process scale.
Customers occasionally propose drop-in replacements, especially on cost grounds. Real process runs teach that saving pennies per kilo often burns many hours and resources further down the line. The combination of bromine and dual fluorines tailors the acid to specific high-value synthesis, making alternates less attractive once all parameters are measured.
Much of the world’s pharmaceutical and agrochemical innovation relies on tight control of building blocks. Each kilo leaving our facility has been tested, inspected, and prepared with the expectation it will end up in a project where every detail counts – from NMR shifts to reactivity to the way it pours from a drum. Years of trial, error, and adjustment have shaped how we produce and deliver 4-Bromo-2,6-Difluorobenzoic Acid to meet evolving scientific and industrial challenges.
Across hundreds of batches, multiple process optimizations, and rigorous analytical investment, the product has become more than a catalog entry. For us, it’s a record of thousands of hours of work—troubleshooting, improving, and responding to changing demands. Direct manufacturer experience proves that real process chemistry depends not just on raw formulae, but on hands-on adjustments that deliver consistent results where it matters most.